- Advanced search
- Immuno Portal
- Malaria Portal
|International Nonproprietary Names|
|MetMAb | OA-5D5 | OA5D5 | PRO 143966|
|Onartuzumab is an investigational, humanized monoclonal antibody targeting the MET receptor tyrosine kinase, a proto-oncogene which acts as a hepatocyte growth factor receptor. The protein is a monovalent (single-armed) construct, as opposed to bi-valent intact antibody structures.
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record.
BLAST peptide analysis reveals identical match with sequences deposited with patent US7615529 , which relate to the monoclonal isolated from hybridoma 5D5.11.6 therein.
|GtoPdb PubChem SID||310264746|
|Search PubMed clinical trials||onartuzumab|
|Search PubMed titles||onartuzumab|
|Search PubMed titles/abstracts||onartuzumab|